Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background. Blood-brain barrier (BBB) dysfunction may have a significant role in the pathogenesis of Alzheimer's disease (AD). Modifiable factors associated with BBB function may have therapeutic implication. This study tested the hypothesis that dyslipidemia is associated with BBB impairment in mild-to-moderate AD. Methods. Thirty-six subjects with AD were followed for 1 year. Fasting CSF and plasma were collected with clinical assessments at baseline and 12 months. BBB impairment was defined as CSF albumin index ≥9. Independent t-tests and linear regression assessed the relationship between plasma lipoproteins and BBB integrity. Results. Dyslipidemia was prevalent in 47 of the population, and in 75 of those with BBB impairment. Subjects with BBB impairment had significantly higher mean plasma triglyceride and lower HDL cholesterol (TG, P = 0.007; HDL, P = 0.043). Plasma triglycerides explained 22 of the variance in BBB integrity and remained significant after controlling for age, gender, ApoE-4 genotype, blood pressure, and statin use. Conclusion. Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease.

Original languageEnglish (US)
Article number184042
JournalCurrent Gerontology and Geriatrics Research
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Dyslipidemias
Blood-Brain Barrier
Alzheimer Disease
Triglycerides
HDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Apolipoproteins E
Lipoproteins
Albumins
Linear Models
Fasting
Genotype
Blood Pressure

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. / Bowman, Gene; Kaye, Jeffrey; Quinn, Joseph.

In: Current Gerontology and Geriatrics Research, Vol. 2012, 184042, 2012.

Research output: Contribution to journalArticle

@article{0a8b99d6ba2f498f90d1fc9f077716ad,
title = "Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease",
abstract = "Background. Blood-brain barrier (BBB) dysfunction may have a significant role in the pathogenesis of Alzheimer's disease (AD). Modifiable factors associated with BBB function may have therapeutic implication. This study tested the hypothesis that dyslipidemia is associated with BBB impairment in mild-to-moderate AD. Methods. Thirty-six subjects with AD were followed for 1 year. Fasting CSF and plasma were collected with clinical assessments at baseline and 12 months. BBB impairment was defined as CSF albumin index ≥9. Independent t-tests and linear regression assessed the relationship between plasma lipoproteins and BBB integrity. Results. Dyslipidemia was prevalent in 47 of the population, and in 75 of those with BBB impairment. Subjects with BBB impairment had significantly higher mean plasma triglyceride and lower HDL cholesterol (TG, P = 0.007; HDL, P = 0.043). Plasma triglycerides explained 22 of the variance in BBB integrity and remained significant after controlling for age, gender, ApoE-4 genotype, blood pressure, and statin use. Conclusion. Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease.",
author = "Gene Bowman and Jeffrey Kaye and Joseph Quinn",
year = "2012",
doi = "10.1155/2012/184042",
language = "English (US)",
volume = "2012",
journal = "Current Gerontology and Geriatrics Research",
issn = "1687-7063",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

AU - Bowman, Gene

AU - Kaye, Jeffrey

AU - Quinn, Joseph

PY - 2012

Y1 - 2012

N2 - Background. Blood-brain barrier (BBB) dysfunction may have a significant role in the pathogenesis of Alzheimer's disease (AD). Modifiable factors associated with BBB function may have therapeutic implication. This study tested the hypothesis that dyslipidemia is associated with BBB impairment in mild-to-moderate AD. Methods. Thirty-six subjects with AD were followed for 1 year. Fasting CSF and plasma were collected with clinical assessments at baseline and 12 months. BBB impairment was defined as CSF albumin index ≥9. Independent t-tests and linear regression assessed the relationship between plasma lipoproteins and BBB integrity. Results. Dyslipidemia was prevalent in 47 of the population, and in 75 of those with BBB impairment. Subjects with BBB impairment had significantly higher mean plasma triglyceride and lower HDL cholesterol (TG, P = 0.007; HDL, P = 0.043). Plasma triglycerides explained 22 of the variance in BBB integrity and remained significant after controlling for age, gender, ApoE-4 genotype, blood pressure, and statin use. Conclusion. Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease.

AB - Background. Blood-brain barrier (BBB) dysfunction may have a significant role in the pathogenesis of Alzheimer's disease (AD). Modifiable factors associated with BBB function may have therapeutic implication. This study tested the hypothesis that dyslipidemia is associated with BBB impairment in mild-to-moderate AD. Methods. Thirty-six subjects with AD were followed for 1 year. Fasting CSF and plasma were collected with clinical assessments at baseline and 12 months. BBB impairment was defined as CSF albumin index ≥9. Independent t-tests and linear regression assessed the relationship between plasma lipoproteins and BBB integrity. Results. Dyslipidemia was prevalent in 47 of the population, and in 75 of those with BBB impairment. Subjects with BBB impairment had significantly higher mean plasma triglyceride and lower HDL cholesterol (TG, P = 0.007; HDL, P = 0.043). Plasma triglycerides explained 22 of the variance in BBB integrity and remained significant after controlling for age, gender, ApoE-4 genotype, blood pressure, and statin use. Conclusion. Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=84862278854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862278854&partnerID=8YFLogxK

U2 - 10.1155/2012/184042

DO - 10.1155/2012/184042

M3 - Article

C2 - 22654903

AN - SCOPUS:84862278854

VL - 2012

JO - Current Gerontology and Geriatrics Research

JF - Current Gerontology and Geriatrics Research

SN - 1687-7063

M1 - 184042

ER -